Bioequivalence Study: 2 mg Estradiol Valerate (EV) and 3 mg Dienogest (DNG) Without and With Levomefolate Calcium
Status:
Completed
Trial end date:
2010-01-01
Target enrollment:
Participant gender:
Summary
Investigation of the bioequivalence (BE) of Estradiol Valerate (EV) and Dienogest (DNG) after
administration of one film-coated tablet containing 2 mg Estradiol Valerate, 3 mg Dienogest
and 0.451 mg Levomefolate calcium as compared to one film-coated tablet containing 2 mg
Estradiol Valerate,3 mg Dienogest.Investigation of the bioequivalence of levomefolate calcium
after administration of one film-coated tablet containing 2 mg Estradiol Valerate, 3 mg
Dienogest and 0.451 mg Levomefolate calcium as compared to one film-coated tablet containing
0.451 mg levomefolate calcium